Serge K. Lyashchenko

Director

Serge K. Lyashchenko

Director
Share
Share
Pictured: Serge Lyashchenko

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Serge K. Lyashchenko discloses the following relationships and financial interests:

  • Evergreen Theragnostics
    Equity; Fiduciary Role / Position; Professional Services and Activities (Uncompensated)
  • International Atomic Energy Agency (IAEA)
    Professional Services and Activities (Uncompensated)
  • Solve Therapeutics, Inc.
    Professional Services and Activities
  • University of California
    Professional Services and Activities
  • Y-mAbs Therapeutics, Inc.
    Professional Services and Activities (Uncompensated)

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures